Anthony Scarsella
Family Medicine · Beverly Hills, CANPI 1902901010
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,445 of the $9,829 with a category attached, or 85.9%. It is spread thinly across 34 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $3,484 and has fallen 99.4% since, to $20 in 2024. Among family medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 502 payments — averaging $19.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$2K
- Merck$2K
- Viiv Healthcare Company$1K
- EMD Serono, Inc.$796
- Novo Nordisk$646
- Napo Pharmaceuticals Inc$516
- plus $3K from 28 others
Across 314 payments — averaging $7724.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$1.5M
- Merck$494K
- Viiv Healthcare Company$381K
- AbbVie$78K
- Janssen Research & Development, LLC$17K
What the payments were for
- Speaking & faculty fees$3764%
- Travel & lodging$9279%
- Food & beverage$8,44586%
- Education$811%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 105 | $1,963 |
| Merck | 28 | $1,664 |
| Viiv Healthcare Company | 96 | $1,352 |
| EMD Serono, Inc. | 46 | $796 |
| Novo Nordisk | 41 | $646 |
| Napo Pharmaceuticals Inc | 37 | $516 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $441 |
| Johnson & Johnson | 21 | $345 |
| Amgen(2 entities) | 12 | $278 |
| AbbVie(2 entities) | 12 | $268 |
| Antares Pharma, Inc. | 13 | $233 |
| Theratechnologies Inc. | 11 | $226 |
| GSK | 6 | $118 |
| Arbor Pharmaceuticals, Inc. | 5 | $113 |
| Janssen Products, LP | 2 | $81 |
| Biohaven Pharmaceuticals, Inc. | 4 | $80 |
| Nestle Healthcare Nutrition Inc. | 4 | $79 |
| Eisai Inc. | 5 | $75 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $71 |
| Lilly USA, LLC | 3 | $54 |
| Teva Pharmaceuticals USA, Inc. | 3 | $50 |
| Pfizer | 3 | $44 |
| Hologic Sales And Service, LLC | 2 | $41 |
| Endo Pharmaceuticals Inc. | 3 | $39 |
| Bausch Health US, LLC | 2 | $38 |
| Dynavax Technologies Corporation | 2 | $38 |
| GRT US Holding, Inc. | 1 | $34 |
| MDD US Operations, LLC | 2 | $30 |
| Redhill Biopharma Inc. | 1 | $25 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Optos, Inc. | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| AstraZeneca | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MK-8591A$1,076
How this compares
$9,829 in reported general payments places this provider in the 95th percentile of 10,533 family medicine providers in California.
Other family medicine in Beverly Hills
- Marcus TellezBeverly Hills$84K
- Sherly SoleimanEncino$1.2M
- Pamela KushnerLos Angeles$1.2M
- Sujata NarayanStanford$1.2M
- Jeffrey UngerChino$906K
- Alexander RivkinLos Angeles$866K
- Scott HowellLos Angeles$793K
- Derrick ButlerLos Angeles$692K
- Sandra CalmanMontara$589K
- Anthony JonesOakland$377K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.